Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique

Abstract

Pseudouridine ({Psi}) is the most common non-canonical ribonucleoside present on mammalian non-coding RNAs (ncRNAs), including rRNAs, tRNAs and snRNAs, where it contributes [~]7% of the total uridine level. However, {Psi} constitutes only [~]0.1% of the uridines present on mRNAs and its effect on mRNA function remains unclear. {Psi} residues have been shown to inhibit the detection of exogenous RNA transcripts by host innate immune factors, thus raising the possibility that viruses might have subverted the addition of {Psi} residues to mRNAs by host pseudouridine synthase (PUS) enzymes as a way to inhibit antiviral responses in infected cells. Here, we describe and validate a novel antibody-based {Psi} mapping technique called photo-crosslinking assisted {Psi} sequencing (PA-{Psi}-seq) and use it to map {Psi} residues on not only multiple cellular RNAs but also on the mRNAs and genomic RNA encoded by HIV-1. We describe several 293T-derived cell lines in which human PUS enzymes previously reported to add {Psi} residues to human mRNAs, specifically PUS1, PUS7 and TRUB1/PUS4, were inactivated by gene editing. Surprisingly, while this allowed us to assign several sites of {Psi} addition on cellular mRNAs to each of these three PUS enzymes, the {Psi} sites present on HIV-1 transcripts remained unaffected. Moreover, loss of PUS1, PUS7 or TRUB1 function did not significantly reduce the level of {Psi} residues detected on total human mRNA below the [~]0.1% level seen in wild type cells, thus implying that the PUS enzyme(s) that adds the bulk of {Psi} residues to human mRNAs remains to be defined.